Kazuhiko Nakagawa

Researcher Next ID · RN-004834

Researcher · Medicine

Osaka, Japan

Not currently recruitingFunding unknown

Research interests

Medicine

Lung Cancer Treatments and Mutations

Lung Cancer Research Studies

Lung Cancer Diagnosis and Treatment

Colorectal Cancer Treatments and Studies

Cancer Immunotherapy and Biomarkers

Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study
The Lancet Oncology · 2020 · https://doi.org/10.1016/s1470-2045(20)30445-9
First-Line Crizotinib versus Chemotherapy in ALK -Positive Lung Cancer
New England Journal of Medicine · 2014 · https://doi.org/10.1056/nejmoa1408440
Crizotinib versus Chemotherapy in Advanced ALK -Positive Lung Cancer
New England Journal of Medicine · 2013 · https://doi.org/10.1056/nejmoa1214886
Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial
The Lancet Oncology · 2009 · https://doi.org/10.1016/s1470-2045(09)70364-x
Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer
Journal of Clinical Oncology · 2003 · https://doi.org/10.1200/jco.2003.10.038

No projects listed.